-+ 0.00%
-+ 0.00%
-+ 0.00%

*Merck: 2Q Januvia/Janumet Sales Fell Primarily Due to Lower Demand and Net Pricing in U.S. Due to Competition and Lower Demand in China and Most Other Intl Mkts Due to Ongoing Generic Competition >MRK

Dow Jones·08/04/2026 10:30:00

Please log in to view news